Intervention strategies for type 2 diabetes prevention targeting low socioeconomic groups: protocol for a scoping review
DOI:
https://doi.org/10.57177/idn.v18.336Keywords:
intervention studies, low socioeconomic status, prediabetes, type 2 diabetesAbstract
Introduction: Type 2 diabetes (T2D) is a public health issue with increasing prevalence, projected to affect 1.27 billion people in 2050. Its onset can largely be prevented or delayed by lifestyle changes. Access to screening is crucial for early diagnosis and treatment to avoid complications due to long-term elevated blood glucose levels. Studies have shown that populations with low socioeconomic status (SES) are among those groups that are more prone to developing T2D. With rising incidence and prevalence of the disease, prevention measures specifically targeting vulnerable groups such as socioeconomically disadvantaged populations, become increasingly relevant. The objective of the scoping review is to investigate what types of interventions have been tested and reported regarding prevention of T2D targeting low socioeconomic populations and that are applicable in a high-income country.
Methods: Studies addressing T2D prevention interventions tailored for populations with low SES that are applicable in high-income countries will be included. A systematic search strategy to identify peer-reviewed literature was developed in consultation with research librarians. Databases searched are Cinahl, PubMed and Web of Science. Interventional studies of various designs will be included and the researchers will independently assess studies for inclusion. The results of the study inclusion process will be reported in the final scoping review and presented in a Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping review (PRISMA-ScR) flow diagram. Analysis of the data will be presented using a narrative approach, as studies are expected to have heterogeneous design features and variable outcome measures.
Discussion: The results will provide an overview of tested T2D prevention intervention studies targeting populations with low SES and will be used to inform and guide the research team and healthcare management for future interventions in Malmö.
Downloads
References
Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature 2019; 576(7785): 51–60. doi: 10.1038/s41586-019-1797-8
World Health Organization. Classification of diabetes mellitus [Internet]. World Health Organization; 2019. Available from: https://www.who.int/publications/i/item/classification-of-diabetes-mellitus [cited 21 September 2023].
Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL, Sacre JW, Karuranga S, et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes Res Clin Pract 2022; 183: 109118. doi: 10.1016/j.diabres.2021.109118
ADA. American Diabetes Association – Standards of care in diabetes – 2023. American Diabetes Association; 2023. Available from: professional.diabetes.org/standards [cited 25 September 2023].
Konieczna J, Ruiz-Canela M, Galmes-Panades AM, Abete I, Babio N, Fiol M, et al. An energy-reduced mediterranean diet, physical activity, and body composition: an interim subgroup analysis of the PREDIMED-plus randomized clinical trial. JAMA Netw Open 2023; 6(10): e2337994. doi: 10.1001/jamanetworkopen.2023.37994
Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, Peters C, Barnes AC, Aribisala BS, et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for β cell recovery. Cell Metab 2018; 28(4): 547–56.e3. doi: 10.1016/j.cmet.2018.07.003
Galmes-Panades AM, Konieczna J, Abete I, Colom A, Rosique-Esteban N, Zulet MA, et al. Lifestyle factors and visceral adipose tissue: results from the PREDIMED-PLUS study. PLoS One 2019; 14(1): e0210726. doi: 10.1371/journal.pone.0210726
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract 2022; 183: 109119. doi: 10.1016/j.diabres.2021.109119
GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023; 402(10397): 203–34. doi: 10.1016/S0140-6736(23)01301-6
Malmö stad. Facts and statistics / Population. Malmö stad; 2024. Available from: https://malmo.se/Facts-and-statistics/Population.html [cited 16 October 2024].
Whiting D UN, Roglic G. Diabetes: equity, social determinants and public health programmes. World Health Organization; 2010. Available from: https://www.who.int/publications/i/item/9789241563970 [cited 09 October 2023].
Kyrou I, Tsigos C, Mavrogianni C, Cardon G, Van Stappen V, Latomme J, et al. Sociodemographic and lifestyle-related risk factors for identifying vulnerable groups for type 2 diabetes: a narrative review with emphasis on data from Europe. BMC Endocr Disord 2020; 20(Suppl 1): 134. doi: 10.1186/s12902-019-0463-3
Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol 2011; 40(3): 804–18. doi: 10.1093/ije/dyr029
Elgart JF, Marín GH, Silvestrini Viola C, Gagliardino JJ. Risk of developing type 2 diabetes according to FINDRISC and socioeconomic status. J Public Health 2022; 30(7): 1785–90. doi: 10.1007/s10389-021-01493-2
Rämgård M, Zdravkovic S, Grahn M, Schölin T, Holmberg CN, Gershater MA. Inequalities in diabetes type 2 prevalence in the multicultural city Malmö, Sweden…14th European Public Health Conference (Virtual), Public health futures in a changing world, November 10–12, 2021 [Internet]. European Journal of Public Health; 2021. Available from: https://research.ebsco.com/linkprocessor/plink?id=6b330eb3-5b28-3ffa-8e9f-0d7883753e37 [cited 30 January 2024].
Bennet L, Johansson SE, Agardh CD, Groop L, Sundquist J, Råstam L, et al. High prevalence of type 2 diabetes in Iraqi and Swedish residents in a deprived Swedish neighbourhood – a population based study. BMC Public Health 2011; 11: 303. doi: 10.1186/1471-2458-11-303
Tapager I, Bender AM, Andersen I. A decade of socioeconomic inequality in type 2 diabetes area-level prevalence: an unshakeable status quo? Scand J Public Health 2023; 51(2): 268–74. doi: 10.1177/14034948211062308
Boverket. Statistik om segregation i Sverige. Boverket; 2021. Available from: https://segregationsbarometern.boverket.se/ [cited 21 September 2023].
International Diabetes Federation. Type 2 diabetes. International Diabetes Federation; 2023. Available from: https://idf.org/about-diabetes/type-2-diabetes/ [cited 09 October 2023].
Spencer Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don’t talk about when we talk about preventing type 2 diabetes-addressing socioeconomic disadvantage. JAMA Intern Med 2016; 176(8): 1053–4. doi: 10.1001/jamainternmed.2016.2952
Yu J, Fei K, Fox A, Negron R, Horowitz C. Stress eating and sleep disturbance as mediators in the relationship between depression and obesity in low-income, minority women. Obes Res Clin Pract 2016; 10(3): 283–90. doi: 10.1016/j.orcp.2015.07.010
Marteau T, Kelly M, Hollands G. Changing population behavior and reducing health disparities: exploring the potential of ‘choice architecture’ interventions. AHRQ; 2015. Available from: https://www.repository.cam.ac.uk/items/3a4b8e9c-96c9-40af-a1fc-f6f6d680efaa [cited 18 April 2024].
Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth 2022; 20(4): 953–68. doi: 10.11124/JBIES-21-00242
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth 2020; 18(10): 2119–26. doi: 10.11124/JBIES-20-00167
Joanna Briggs Institute. The Joanna Briggs Institute Reviewers’ Manual 2015. Methodology for JBI Scoping reviews. South Australia: The University of Adelaide; 2015.
Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010; 5: 69. doi: 10.1186/1748-5908-5-69
World Bank. [Internet]. 2024. Available from: https://blogs.worldbank.org/en/opendata/world-bank-country-classifications-by-income-level-for-2024-2025 [cited 20 October 2024].
McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol 2016; 75: 40–6. doi: 10.1016/j.jclinepi.2016.01.021
SBU. Utvärdering av insatser i hälso- och sjukvården och socialtjänsten – En metodbok. 2023. Available from: https://www.sbu.se/sv/metod/metodboken-2023/?lang=sv&pub=101442 [cited 01 February 2024].
Covidence systematic review software. Melbourne, Australia: Veritas Health Innovation. Available from: https://www.covidence.org/ [cited 15 October 2023].
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018; 169(7): 467–73. doi: 10.7326/M18-0850
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Josefine Thylefors, Magdalena Annersten Gershater, Elisabeth Mangrio, Slobodan Zdravkovic
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
